维生素D与非酒精性脂肪性肝病严重程度无关:配对临床与基因表达谱分析结果
该研究比较了39例对照和244例经肝活检的非酒精性脂肪性肝病(NAFLD)成人患者,分析维生素D水平及肝脏维生素D代谢基因表达与NAFLD组织学严重程度的关系。结果显示,校正混杂因素后,维生素D水平与肝脂肪变、小叶或门管区炎症、气球样肝细胞均不相关,维生素D缺乏或相关基因差异表达与肝纤维化或其他组织学特征也无关联。
要点
- NAFLD患者较对照更常出现较高的HbA1c(6.5±1.2 vs 5.9±1.0;P=0.009),但两组间维生素D水平无差异。
- 校正混杂因素后,维生素D水平与肝脂肪变、小叶或门管区炎症、气球样肝细胞严重程度均不相关。
- 维生素D缺乏或肝脏维生素D代谢基因差异表达与肝纤维化或其他NAFLD组织学特征无关联。
核心结论
- 维生素D缺乏及肝脏维生素D相关基因表达均与NAFLD的存在或组织学严重程度无关。
- 尽管临床前证据提示维生素D参与NAFLD发病机制,但在人类中维生素D缺乏似乎与NAFLD严重程度不相关。
研究设计与样本
- 研究比较了两个成人队列:对照39例和经肝活检的NAFLD患者244例。
- 采用双侧t检验或Wilcoxon秩和检验分析连续变量,采用卡方检验或Fisher精确检验分析分类变量。
- 采用广义线性模型分析维生素D水平及维生素D代谢基因与NAFLD组织学严重程度的关联,并校正潜在混杂因素及多重比较。
主要发现
- NAFLD患者较对照更常出现较高的HbA1c(6.5±1.2 vs 5.9±1.0;P=0.009),HbA1c是维生素D缺乏的危险因素。
- 两组间维生素D水平无差异。
- 校正混杂因素后,维生素D水平与肝脂肪变、小叶或门管区炎症、气球样肝细胞的严重程度均不相关。
- 维生素D缺乏或维生素D代谢相关基因差异表达与肝纤维化严重程度或NAFLD其他组织学特征均无关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The pathogenesis of nonalcoholic fatty liver disease (NAFLD) is complex. Vitamin D (VitD) has been implicated in NAFLD pathogenesis because it has roles in immune modulation, cell differentiation and proliferation, and regulation of inflammation. We evaluated the association of VitD levels, hepatic gene expression for VitD metabolizing genes, and NAFLD histological severity. METHODS: Two adult cohorts, controls (n=39) and NAFLD (n=244), who underwent liver biopsy were compared. Two-sided t-tests or Wilcoxon's rank-sum tests for continuous predictors and chi-squared tests or Fisher's exact tests for categorical variables were used to analyze the association of VitD and NAFLD. Generalized linear models were used to analyze the association of VitD levels and VitD metabolizing genes with histological severity of NAFLD while adjusting for potential confounders and correcting for multiple comparisons. RESULTS: NAFLD patients were more likely than controls to have higher HbA1c (6.5±1.2 vs 5.9±1.0; P=0.009), a risk factor for VitD deficiency. However, no difference in VitD levels was observed between groups. VitD levels did not correlate with the severity of hepatic steatosis, lobular or portal inflammation, or ballooned hepatocytes after adjusting for confounding factors. Furthermore, no association was noted between VitD deficiency or differential expression of genes involved in VitD metabolism and severity of hepatic fibrosis or any other histologic feature of NAFLD. CONCLUSIONS: Neither VitD deficiency, nor hepatic expression of VitD-related genes, associate with the presence or histologic severity of NAFLD in patients. Hence, despite preclinical evidence implicating VitD in NAFLD pathogenesis, VitD deficiency does not appear to be associated with NAFLD severity in humans.
引用
- Patel YA, Henao R, Moylan CA, et al. Vitamin D is Not Associated With Severity in NAFLD: Results of a Paired Clinical and Gene Expression Profile Analysis. Am J Gastroenterol. 2016. PMID: 27644736. doi:10.1038/ajg.2016.406
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。